FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036716522> ?p ?o ?g. }

• W2036716522 endingPage "1466" @default.
• W2036716522 startingPage "1457" @default.
• W2036716522 abstract "Initially, tyrosine kinase inhibitors (TKIs) were developed as targeted therapies that would solely interfere with aberrant tyrosine kinase activation in malignant cells. Nevertheless, preclinical and clinical studies demonstrated that TKI also exhibit “off-target” effects, that is effects not mediated by the assumed mechanisms of action. We and others showed that the epidermal growth factor receptor (EGFR) inhibitors erlotinib and gefitinib exert potent antineoplastic effects on EGFR-negative myeloblasts from patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Here, we undertook a side-by-side comparison of the anti-leukemic efficacy of four different TKI in MDS and AML. Besides the EGFR inhibitor erlotinib, which served as a point of reference, we employed the dual EGFR/HER2 TKI lapatinib, as well as the multikinase inhibitors dasatinib and sorafenib. All four drugs had anti-leukemic effects on cell line models of MDS/AML in vitro as well as on malignant blasts from MDS/AML patients ex vivo. We explored the biological phenomena underlying this anti-leukemic efficacy. Since it is established that a therapeutic benefit in MDS/AML can be conveyed by induction of cell cycle arrest, apoptosis and/or differentiation, we deciphered the individual contribution of these three phenomena to the anti-leukemic action of each of the four TKI. The concomitant assessment of the panel of TKI enables us thus to define (and quantify) their differential capacity to impact on the three biological phenomena, and provide further evidence that these mechanisms are not solely explained by on-target effects." @default.
• W2036716522 created "2016-06-24" @default.
• W2036716522 creator A5006206380 @default.
• W2036716522 creator A5007342447 @default.
• W2036716522 creator A5007605254 @default.
• W2036716522 creator A5011803879 @default.
• W2036716522 creator A5011992727 @default.
• W2036716522 creator A5014838075 @default.
• W2036716522 creator A5017435311 @default.
• W2036716522 creator A5048099534 @default.
• W2036716522 creator A5054745373 @default.
• W2036716522 creator A5055806024 @default.
• W2036716522 creator A5075296559 @default.
• W2036716522 creator A5084675513 @default.
• W2036716522 date "2011-11-01" @default.
• W2036716522 modified "2023-10-16" @default.
• W2036716522 title "Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action" @default.
• W2036716522 cites W113889405 @default.
• W2036716522 cites W1492609361 @default.
• W2036716522 cites W1522153085 @default.
• W2036716522 cites W1534965621 @default.
• W2036716522 cites W1963801361 @default.
• W2036716522 cites W1975404029 @default.
• W2036716522 cites W1983971021 @default.
• W2036716522 cites W2026775820 @default.
• W2036716522 cites W2035576418 @default.
• W2036716522 cites W2036803537 @default.
• W2036716522 cites W2062612369 @default.
• W2036716522 cites W2077701124 @default.
• W2036716522 cites W2078503792 @default.
• W2036716522 cites W2080575341 @default.
• W2036716522 cites W2082183475 @default.
• W2036716522 cites W2089122153 @default.
• W2036716522 cites W2090443244 @default.
• W2036716522 cites W2092606584 @default.
• W2036716522 cites W2093447167 @default.
• W2036716522 cites W2094492494 @default.
• W2036716522 cites W2098712005 @default.
• W2036716522 cites W2126058747 @default.
• W2036716522 cites W2142207129 @default.
• W2036716522 cites W2143952085 @default.
• W2036716522 cites W2151222524 @default.
• W2036716522 cites W2157305385 @default.
• W2036716522 cites W2162700652 @default.
• W2036716522 cites W2169355544 @default.
• W2036716522 cites W2171484579 @default.
• W2036716522 cites W4256391755 @default.
• W2036716522 doi "https://doi.org/10.1016/j.bcp.2011.05.011" @default.
• W2036716522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21664897" @default.
• W2036716522 hasPublicationYear "2011" @default.
• W2036716522 type Work @default.
• W2036716522 sameAs 2036716522 @default.
• W2036716522 citedByCount "29" @default.
• W2036716522 countsByYear W20367165222012 @default.
• W2036716522 countsByYear W20367165222013 @default.
• W2036716522 countsByYear W20367165222014 @default.
• W2036716522 countsByYear W20367165222015 @default.
• W2036716522 countsByYear W20367165222016 @default.
• W2036716522 countsByYear W20367165222017 @default.
• W2036716522 countsByYear W20367165222018 @default.
• W2036716522 countsByYear W20367165222019 @default.
• W2036716522 countsByYear W20367165222023 @default.
• W2036716522 crossrefType "journal-article" @default.
• W2036716522 hasAuthorship W2036716522A5006206380 @default.
• W2036716522 hasAuthorship W2036716522A5007342447 @default.
• W2036716522 hasAuthorship W2036716522A5007605254 @default.
• W2036716522 hasAuthorship W2036716522A5011803879 @default.
• W2036716522 hasAuthorship W2036716522A5011992727 @default.
• W2036716522 hasAuthorship W2036716522A5014838075 @default.
• W2036716522 hasAuthorship W2036716522A5017435311 @default.
• W2036716522 hasAuthorship W2036716522A5048099534 @default.
• W2036716522 hasAuthorship W2036716522A5054745373 @default.
• W2036716522 hasAuthorship W2036716522A5055806024 @default.
• W2036716522 hasAuthorship W2036716522A5075296559 @default.
• W2036716522 hasAuthorship W2036716522A5084675513 @default.
• W2036716522 hasConcept C121608353 @default.
• W2036716522 hasConcept C126322002 @default.
• W2036716522 hasConcept C170493617 @default.
• W2036716522 hasConcept C203014093 @default.
• W2036716522 hasConcept C2777329042 @default.
• W2036716522 hasConcept C2777583451 @default.
• W2036716522 hasConcept C2778019345 @default.
• W2036716522 hasConcept C2778087573 @default.
• W2036716522 hasConcept C2778461978 @default.
• W2036716522 hasConcept C2778695046 @default.
• W2036716522 hasConcept C2778729363 @default.
• W2036716522 hasConcept C2778820342 @default.
• W2036716522 hasConcept C2779282312 @default.
• W2036716522 hasConcept C2779438470 @default.
• W2036716522 hasConcept C2779536868 @default.
• W2036716522 hasConcept C2779786085 @default.
• W2036716522 hasConcept C2780580887 @default.
• W2036716522 hasConcept C42362537 @default.
• W2036716522 hasConcept C502942594 @default.
• W2036716522 hasConcept C530470458 @default.
• W2036716522 hasConcept C71924100 @default.
• W2036716522 hasConcept C98274493 @default.
• W2036716522 hasConceptScore W2036716522C121608353 @default.

• next